BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 15647651)

  • 81. Rabeprazole: an update of its use in acid-related disorders.
    Carswell CI; Goa KL
    Drugs; 2001; 61(15):2327-56. PubMed ID: 11772142
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Lansoprazole: in the treatment of gastro-oesophageal reflux disease in children and adolescents.
    Croom KF; Scott LJ
    Drugs; 2005; 65(15):2129-35; discussion 2136-7. PubMed ID: 16225368
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Efficacy of controloc in the treatment of acid-dependent diseases].
    Chubenko SS; Gaĭdukov VO; Agibalov AN; Onishenko AV
    Lik Sprava; 2003 Dec; (8):103-4. PubMed ID: 14965022
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Comparable clinical efficacy and tolerability of 20 mg pantoprazole and 20 mg omeprazole in patients with grade I reflux oesophagitis.
    Bardhan KD; Van Rensburg C
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1585-91. PubMed ID: 11563998
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The basis for the decreased response to proton pump inhibitors in gastro-oesophageal reflux disease patients without erosive oesophagitis.
    Gardner JD; Gallo-Torres H; Sloan S; Robinson M; Miner PB
    Aliment Pharmacol Ther; 2003 Nov; 18(9):891-905. PubMed ID: 14616153
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Ex juvantibus approach for chronic posterior laryngitis: results of short-term pantoprazole therapy.
    Habermann W; Eherer A; Lindbichler F; Raith J; Friedrich G
    J Laryngol Otol; 1999 Aug; 113(8):734-9. PubMed ID: 10748849
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Proton pump inhibitors or surgery for gastro-oesophageal reflux disease.
    Hinder RA
    Dig Liver Dis; 2002 Feb; 34(2):95-6. PubMed ID: 11926565
    [No Abstract]   [Full Text] [Related]  

  • 88. Lansoprazole: an update of its place in the management of acid-related disorders.
    Matheson AJ; Jarvis B
    Drugs; 2001; 61(12):1801-33. PubMed ID: 11693467
    [TBL] [Abstract][Full Text] [Related]  

  • 89. New-generation proton pump inhibitors: overcoming the limitations of early-generation agents.
    Robinson M
    Eur J Gastroenterol Hepatol; 2001 May; 13 Suppl 1():S43-7. PubMed ID: 11430508
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Pantoprazole, Prout and the proton pump.
    Playford RJ; Podas T; Modlin I
    Hosp Med; 1999 Jul; 60(7):500-4. PubMed ID: 10605542
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Direct comparative trials of the efficacy of proton pump inhibitors in the management of gastro-oesophageal reflux disease and peptic ulcer disease.
    Vakil N; Fennerty MB
    Aliment Pharmacol Ther; 2003 Sep; 18(6):559-68. PubMed ID: 12969082
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Treatment of reflux oesophagitis of moderate and severe grade with ranitidine or pantoprazole--comparison of 24-hour intragastric and oesophageal pH.
    Armbrecht U; Abucar A; Hameeteman W; Schneider A; Stockbrügger RW
    Aliment Pharmacol Ther; 1997 Oct; 11(5):959-65. PubMed ID: 9354207
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Relapse prevention in reflux oesophagitis with regard to Helicobacter pylori status: a double-blind, randomized, multicentre trial to compare the efficacy of pantoprazole versus ranitidine.
    Adamek RJ; Behrendt J; Wenzel C
    Eur J Gastroenterol Hepatol; 2001 Jul; 13(7):811-7. PubMed ID: 11474311
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Review article: relief of symptoms in gastric acid-related diseases--correlation with acid suppression in rabeprazole treatment.
    Miner P
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():20-9. PubMed ID: 15496215
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The basis of differentiation of PPIs.
    Sachs G; Shin JM
    Drugs Today (Barc); 2004 Mar; 40 Suppl A():9-14. PubMed ID: 15190382
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Pantoprazole.
    Poole P
    Am J Health Syst Pharm; 2001 Jun; 58(11):999-1008. PubMed ID: 11402494
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The pharmacology and clinical relevance of proton pump inhibitors.
    Katz PO; Frissora C
    Curr Gastroenterol Rep; 2002 Dec; 4(6):459-62. PubMed ID: 12441035
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The effect of acid suppression on sleep patterns and sleep-related gastro-oesophageal reflux.
    Orr WC; Goodrich S; Robert J
    Aliment Pharmacol Ther; 2005 Jan; 21(2):103-8. PubMed ID: 15679759
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Laparoscopic fundoplication versus lansoprazole for gastro-oesophageal reflux disease. A pH-metric comparison.
    Frazzoni M; Grisendi A; Lanzani A; Melotti G; De Micheli E
    Dig Liver Dis; 2002 Feb; 34(2):99-104. PubMed ID: 11926567
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Proton-pump inhibitors: three of a kind?
    Bateman DN
    Lancet; 1997 Jun; 349(9066):1637-8. PubMed ID: 9186377
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.